UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 235

Sortiert nach

Antibody–Drug Conjugates: The Last Decade

Pharmaceuticals (Basel, Switzerland), 2020-09, Vol.13 (9), p.245

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of cathepsin B-sensitive triggers and hydrophilic linkers on in vitro efficacy of novel site-specific antibody-drug conjugates

Organic & biomolecular chemistry, 2018, Vol.16 (11), p.1882-1889

2018

Link zum Volltext

Verfügbarkeit prüfen

Modular and Practical Synthesis of 6-Substituted Pyridin-3-yl C-Nucleosides

Journal of organic chemistry, 2007-08, Vol.72 (18), p.6797-6805

2007

Link zum Volltext

Verfügbarkeit prüfen

Intra-Domain Cysteines (IDC), a New Strategy for the Development of Original Antibody Fragment–Drug Conjugates (FDCs)

Pharmaceutics, 2022-08, Vol.14 (8), p.1524

2022

Link zum Volltext

Verfügbarkeit prüfen

Dynamic input loads evaluation of a recreational vehicle frame using multibody dynamics hybrid modeling validated with experimental and full analytical modeling data

Advances in mechanical engineering, 2021-08, Vol.13 (8), p.168781402110346

2021

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological Characterization of Low Molecular Weight Biased Agonists at the Follicle Stimulating Hormone Receptor

International journal of molecular sciences, 2021-09, Vol.22 (18), p.9850-23

2021

Link zum Volltext

Verfügbarkeit prüfen

Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cells

Cell & bioscience, 2023-04, Vol.13 (1), p.72-72, Article 72

2023

Link zum Volltext

Verfügbarkeit prüfen

Internalization of Foldamer-Based DNA Mimics through a Site-Specific Antibody Conjugate to Target HER2-Positive Cancer Cells

Pharmaceuticals (Basel, Switzerland), 2021-06, Vol.14 (7), p.624

2021

Link zum Volltext

Verfügbarkeit prüfen

Potassium 6-Oxo-7,13,16,22-tetraazatetracyclo[12.6.2.18,12.017,21]tricosa-1(20),8(23),9,11,14,16,18,21-octaen-2-yne-15-carboxylate

MolBank, 2023-12, Vol.2023 (4), p.M1735

2023

Link zum Volltext

Verfügbarkeit prüfen

Increment in Drug Loading on an Antibody–Drug Conjugate Increases Its Binding to the Human Neonatal Fc Receptor in Vitro

Molecular pharmaceutics, 2016-04, Vol.13 (4), p.1405-1412

2016

Link zum Volltext

Verfügbarkeit prüfen

Mild, base-free copper-catalyzed N-arylations of heterocycles using potassium aryltrifluoroborates in water under air

Tetrahedron letters, 2010-06, Vol.51 (22), p.2994-2997

2010

Link zum Volltext

Verfügbarkeit prüfen

Impact of Maleimide Disubstitution on Chemical and Biological Characteristics of HER2 Antibody–Drug Conjugates

ACS omega, 2020-01, Vol.5 (3), p.1557-1565

2020

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of 6-Substituted 2(1H)-Pyridon-3-yl C-2′-Deoxyribonucleosides

European Journal of Organic Chemistry, 2012-03, Vol.2012 (9), p.1759-1767

2012

Link zum Volltext

Verfügbarkeit prüfen

Towards antibody-drug conjugates and prodrug strategies with extracellular stimuli-responsive drug delivery in the tumor microenvironment for cancer therapy

European journal of medicinal chemistry, 2017-12, Vol.142, p.393-415

2017

Link zum Volltext

Verfügbarkeit prüfen

Protein Kinase A-independent Activation of ERK and H,K-ATPase by cAMP in Native Kidney Cells

The Journal of biological chemistry, 2002-05, Vol.277 (21), p.18598-18604

2002

Link zum Volltext

Verfügbarkeit prüfen

Antibody-drug conjugates in oncology. New strategies in development

M.S. Médecine sciences, 2020-01, Vol.35 (12), p.1043

2020

Link zum Volltext

Verfügbarkeit prüfen

Antibody-drug conjugates in oncology. Recent success of an ancient concept

M.S. Médecine sciences, 2020-01, Vol.35 (12), p.1034

2020

Link zum Volltext

Verfügbarkeit prüfen

Palladium-Catalyzed Amination of N‑Free 2‑Chloro-7-azaindole

Organic letters, 2015-10, Vol.17 (19), p.4710-4713

2015

Link zum Volltext

Verfügbarkeit prüfen

Branched pegylated linker-auristatin to control hydrophobicity for the production of homogeneous minibody-drug conjugate against HER2-positive breast cancer

Journal of controlled release, 2024-02, Vol.366, p.567-584

2024

Link zum Volltext

Verfügbarkeit prüfen

Dual intra- and extracellular release of monomethyl auristatin E from a neutrophil elastase-sensitive antibody-drug conjugate

European journal of medicinal chemistry, 2022-02, Vol.229, p.114063-114063, Article 114063

2022

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic antibodies – natural and pathological barriers and strategies to overcome them

Pharmacology & therapeutics (Oxford), 2022-05, Vol.233, p.108022-108022, Article 108022

2022

Link zum Volltext

Verfügbarkeit prüfen

Site-Specific Conjugation of Auristatins onto Engineered scFv Using Second Generation Maleimide to Target HER2-positive Breast Cancer in Vitro

Bioconjugate chemistry, 2018-11, Vol.29 (11), p.3516-3521

2018

Link zum Volltext

Verfügbarkeit prüfen

Frame loads accuracy assessment of semianalytical multibody dynamic simulation methods of a recreational vehicle

Multibody system dynamics, 2020, Vol.50 (2), p.189-209

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of Site-Specific Conjugation of ScFv to Multifunctional Nanomedicines Using Second Generation Maleimide

Bioconjugate chemistry, 2018-05, Vol.29 (5), p.1553-1559

2018

Link zum Volltext

Verfügbarkeit prüfen

Intra-Domain Cysteines

Pharmaceutics, 2022-07, Vol.14 (8)

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 235

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(207)
Mit Volltextzugriff
(223)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Antibody–Drug Conjugates: The Last Decade

Impact of cathepsin B-sensitive triggers and hydrophilic linkers on in vitro efficacy of novel site-specific antibody-drug conjugates

Modular and Practical Synthesis of 6-Substituted Pyridin-3-yl C-Nucleosides

Intra-Domain Cysteines (IDC), a New Strategy for the Development of Original Antibody Fragment–Drug Conjugates (FDCs)

Dynamic input loads evaluation of a recreational vehicle frame using multibody dynamics hybrid modeling validated with experimental and full analytical modeling data

Pharmacological Characterization of Low Molecular Weight Biased Agonists at the Follicle Stimulating Hormone Receptor

Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cells

Internalization of Foldamer-Based DNA Mimics through a Site-Specific Antibody Conjugate to Target HER2-Positive Cancer Cells

Potassium 6-Oxo-7,13,16,22-tetraazatetracyclo[12.6.2.18,12.017,21]tricosa-1(20),8(23),9,11,14,16,18,21-octaen-2-yne-15-carboxylate

Increment in Drug Loading on an Antibody–Drug Conjugate Increases Its Binding to the Human Neonatal Fc Receptor in Vitro

Mild, base-free copper-catalyzed N-arylations of heterocycles using potassium aryltrifluoroborates in water under air

Impact of Maleimide Disubstitution on Chemical and Biological Characteristics of HER2 Antibody–Drug Conjugates

Synthesis of 6-Substituted 2(1H)-Pyridon-3-yl C-2′-Deoxyribonucleosides

Towards antibody-drug conjugates and prodrug strategies with extracellular stimuli-responsive drug delivery in the tumor microenvironment for cancer therapy

Protein Kinase A-independent Activation of ERK and H,K-ATPase by cAMP in Native Kidney Cells

Antibody-drug conjugates in oncology. New strategies in development

Antibody-drug conjugates in oncology. Recent success of an ancient concept

Palladium-Catalyzed Amination of N‑Free 2‑Chloro-7-azaindole

Branched pegylated linker-auristatin to control hydrophobicity for the production of homogeneous minibody-drug conjugate against HER2-positive breast cancer

Dual intra- and extracellular release of monomethyl auristatin E from a neutrophil elastase-sensitive antibody-drug conjugate

Therapeutic antibodies – natural and pathological barriers and strategies to overcome them

Site-Specific Conjugation of Auristatins onto Engineered scFv Using Second Generation Maleimide to Target HER2-positive Breast Cancer in Vitro

Frame loads accuracy assessment of semianalytical multibody dynamic simulation methods of a recreational vehicle

Impact of Site-Specific Conjugation of ScFv to Multifunctional Nanomedicines Using Second Generation Maleimide

Intra-Domain Cysteines

Suchergebnisse filtern